Paper Details

  1. Home
  2. Paper Details

20 microg versus >20 microg estrogen combined oral contraceptives for contraception.

Author: GalloMaria F, GrimesDavid A, LopezLaureen M, NandaKavita, SchulzKenneth F

Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Concern about estrogen-related adverse effects has led to a decrease in estrogen doses in combination oral contraceptives (COCs). However, reducing estrogen could decrease contraceptive effectiveness and lead to changes in bleeding patterns.
Paper Details　
Original Abstract of the Article :
Concern about estrogen-related adverse effects has led to progressive reductions in the estrogen dose in combination oral contraceptives (COCs). However, reducing the amount of estrogen to improve safety could result in decreased contraceptive effectiveness and unacceptable changes in bleeding patte...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/14651858.CD003989.pub3

データ提供：米国国立医学図書館（NLM）

Navigating the Desert of Estrogen Dosing in Oral Contraceptives

The field of contraception is a complex and ever-evolving desert, where the search for safe and effective methods continues. This research investigates the impact of estrogen dose on the efficacy and safety of combined oral contraceptives (COCs). The study compares the effectiveness and side effect profiles of COCs containing different estrogen doses, seeking to inform clinical practice and guide patient choices.

Balancing the Sands of Efficacy and Safety

The study suggests that reducing estrogen dose in COCs can potentially lead to decreased contraceptive effectiveness and undesirable changes in bleeding patterns. This finding highlights the importance of carefully considering the trade-off between reducing estrogen-related side effects and maintaining contraceptive efficacy.

Finding the Right Oasis in the Desert of Contraception

This research underscores the need for personalized approaches to contraception, taking into account individual patient needs and preferences. Clinicians should carefully weigh the benefits and risks of different COC formulations, considering factors such as estrogen dose, contraceptive efficacy, and potential side effects.

Dr.Camel's Conclusion

This research reminds us that the desert of contraception is a complex and nuanced landscape. By carefully navigating the shifting sands of efficacy and safety, we can ensure that women have access to the most appropriate and effective contraceptive options, maximizing their well-being and reproductive autonomy.

Date :
  1. Date Completed 2009-01-15
  2. Date Revised 2020-05-11
Further Info :

Pubmed ID

18843653

DOI: Digital Object Identifier

10.1002/14651858.CD003989.pub3

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.